Skip to content
Research Article Open access CC BY 4.0

High Dose Methylprednisolone in Fulminant Progressive Quadriparesis with Optic Neurites: The Marburg Variant

Ahmad Ghayas Ansari, Ariba, Lubna Zafar

Asian Journal of Research and Reports in Neurology · pp. 116–120 · Published 28 Aug 2023

Abstract

Marburg described an acute variant of Multiple Sclerosis (MS) which was rare with a fulminant demyelinating progressive course with multiple lesions, predominantly in young adults, leading to severe disability and death within a year of onset. The disease was associated with an Antibody-mediated process, acute fulminant course and typical MRI findings which are diagnostic of the disease. High-dose glucocorticoids, cyclophosphamide and mitoxantrone have shown good response to treatment. The malignant form of MS accounts for less than 4% of the incidence. Here the patient had no history or sign of infectious, metabolic, or vascular pathology and thus the diagnosis of Marburg’s variant was made by exclusion. The Marburg variant is rare and needs a high index of suspicion. In the future, studies of patients with tumefactive demyelinating lesions are necessary for early diagnosis, greater understanding of the disease and for the development of therapeutic strategies.

Multiple sclerosis marburg variant methylprednisolone

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.